Detail akcie Adiuvo Invest online

Business Summary: Adiuvo Investments SA W Restrukturyzacji, formerly Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Adiuvo Investments SA W Restrukturyzacji revenues decreased 66% to PLN334K. Net loss before extraordinary items decreased 58% to PLN4.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects The share of profit of associates decrease of 90% to PLN478K (expense), Interest Income - Non-Bank increase from PLN1.3M to PLN4.8M